Top Markets
#1 Decred Decred +8.72%
#2 Wibx Wibx +8.37%
#3 Status Status +7.35%
#4 SkyAI SkyAI +5.40%
#5 aelf aelf +5.26%
#6 MarsCoin MarsCoin +5.08%
#7 TRIA TRIA +4.98%
#8 Rei Rei +4.63%
#9 Wrapped Flare Wrapped Flare +4.46%
#10 DexNet DexNet +3.98%
Coin of the day
Decred Decred
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
Clasificación en acciones #30680
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Precio por acción
$0.91968646
Última sincronización: 2026-08-18
Capitalización bursátil
$15.91M
Cambio (1 día)
2.23%
Cambio (1 año)
-52.75%
País
KR
Comercio Xcell Therapeutics, Inc. (373110)

Categoría

Healthcare
Ratio P/S de Xcell Therapeutics, Inc. (373110)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Xcell Therapeutics, Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Xcell Therapeutics, Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE